CLEARUM GmbH manufactures and sells synthetic hollow fibers for material separation, which are primarily used as the main component of dialyzers (renal replacement therapy/hemodialysis). The company is located in Poppendorf and belongs indirectly via Mozarc Medical Ireland Limited to Mozarc Medical Holding LLC; the ultimate parent is a joint venture between Medtronic plc and DaVita Inc. In the 2023/2024 financial year CLEARUM reported revenues of EUR 15,696,658.69 and employed 145 persons as of 30 April 2024. Business relations exist both within the group (cost recharges, deliveries to affiliated companies) and with external customers, and the revenue increase in the reporting year was mainly due to higher intra-group sales.
Entwicklung, Herstellung und Vertrieb von Produkten zur stofflichen Trennung von Feststoffen, Flüssigkeiten und Gasen sowie alle damit verbundenen Serviceleistungen.
Converted using the official Destatis and Eurostat correspondence tables; ISIC Rev. 4 is the United Nations' international industry classification.
This summary was generated with the help of AI. See our Data Quality Notice. Report error?
Source: German Commercial Register (Handelsregister) Rostock Local Court, HRB 13037 (as of 1 November 2026)
| Name | Type | City |
|---|---|---|
| Mingye Gong | Geschäftsführer(in) | Lund |
Source: German Commercial Register (Handelsregister) Rostock Local Court, HRB 13037 (as of 1 November 2026)
| Year | Revenue | Profit | Balance | Employees |
|---|---|---|---|---|
| 2025 | €15,735,160 | -€7,846,301 | €38,247,360 | — |
| 2024 | €15,696,659 | -€8,147,399 | €39,648,413 | — |
| 2023 | €15,164,496 | -€5,123,392 | €40,130,241 | — |
| 2022 | €14,969,365 | -€6,037,659 | €31,323,989 | — |
| 2021 | €15,014,182 | -€7,059,563 | €34,331,615 | — |
| 2020 | €13,355,510 | -€4,471,908 | €40,260,173 | — |
| 2019 | €3,857,000 | -€18,241,925 | €30,718,914 | — |
| 2018 | Rohergebnis-€392.2K2 | -€16,933,516 | €42,134,661 | — |
| 2017 | Rohergebnis€12.3M2 | €1,068,041 | €46,740,325 | — |
| 2016 | Rohergebnis€4.1M2 | -€4,693,570 | €44,575,268 | — |
1 Small companies are not required to publish a profit-and-loss statement (§ 326 (1) HGB). The figure shown is the statutory ceiling under § 267 HGB where the balance-sheet total makes it binding — a company may exceed at most one of the three size criteria.
2 Rohergebnis nach § 276 HGB: Umsatzerlöse abzüglich Materialaufwand bzw. Herstellungskosten. Kleine und mittelgroße Kapitalgesellschaften dürfen diese Posten zusammenfassen; die Umsatzerlöse selbst sind dann nicht veröffentlicht und liegen über dem Rohergebnis.
Sign in to download data
Source: German Commercial Register (Handelsregister) Rostock Local Court, HRB 13037 (as of 1 November 2026)
| Cost type | Amount | Share |
|---|---|---|
| Personnel Costs | €8,885,125 | 78.2% |
| Depreciation | €2,447,769 | 21.5% |
| Interest & Similar | €32,402 | 0.3% |
